Activation of Macrophages by Vitamin D-Binding Protein

Yamamoto, Nobuto

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research Project (R01)
• Project #: 5R01AI032140-02
• Application #: 3147189
• Study Section: Experimental Immunology Study Section (EI)
• Project Start: 1992-01-01
• Project End: 1993-05-31
• Budget Start: 1993-01-01
• Budget End: 1993-05-31
• Support Year: 2
• Fiscal Year: 1993

Institution

• Name: Temple University
• Type: Schools of Medicine
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19122

Publications

Yamamoto, Nobuto; Ushijima, Naofumi; Koga, Yoshihiko (2009) Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). J Med Virol 81:16-26

Yamamoto, Nobuto; Suyama, Hirofumi; Nakazato, Hiroaki et al. (2008) Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. Cancer Immunol Immunother 57:1007-16

Yamamoto, Nobuto; Suyama, Hirofumi; Yamamoto, Nobuyuki et al. (2008) Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer 122:461-7

Yamamoto, Nobuto (2006) Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1. AIDS Res Hum Retroviruses 22:262-71

Yamamoto, Nobuto; Urade, Masahiro (2005) Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus. Microbes Infect 7:674-81

Koga, Y; Naraparaju, V R; Yamamoto, N (1999) Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice. Proc Soc Exp Biol Med 220:20-6

Korbelik, M; Naraparaju, V R; Yamamoto, N (1998) The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy. Br J Cancer 77:1009-14

Yamamoto, N; Naraparaju, V R (1998) Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization. Immunol Cell Biol 76:237-44

Yamamoto, N; Naraparaju, V R (1997) Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor. Cancer Res 57:2187-92

Yamamoto, N; Naraparaju, V R; Urade, M (1997) Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients. Cancer Res 57:295-9